Credit Suisse names pharma acquisition targets

• Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) by Abbott Laboratories (NYSE:ABT), Bristol-Myers Squibb Co. (NYSE:BMY) or Eli Lilly and Co. (NYSE:LLY);
• Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) by Eli Lilly;
• Biomarin Pharmaceutical Inc.(NASDAQ:BMRN) by Abbott, Bristol-Myers Squibb or Eli Lilly;
• Rigel Pharmaceutical Inc. (NASDAQ:RIGL) by Abbott, Bristol Myers Squibb or Johnson & Johnson (NYSE:JNJ);
• Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) by Forest Laboratories Inc. (NYSE:FRX); and
• Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) by Bristol-Myers Squibb, Gilead Sciences Inc. (NASDAQ:GILD) or Johnson & Johnson.

Source